Skip to main content
AAN.com
Article
March 1, 1997

Clinical-neuropathologic findings in multi-infarct dementia
A report of six autopsied cases

March 1997 issue
48 (3) 668-672

Abstract

Article abstract-To clarify the neuropathologic criteria for the diagnosis of vascular dementia principally caused by large-vessel cerebral infarction, we solicited autopsy cases of vascular dementia from 10 university neuropathology laboratories. We included only those cases with progressive dementia clinically diagnosed as Alzheimer's disease (AD) or multi-infarct dementia, in whom autopsy revealed only cerebral infarction, without significant neuropathologic features of AD or other neurodegenerative disorders. Only six cases, all men, met these criteria. Each of them had, for a year or longer, gradually increasing cognitive impairment sufficient to interfere with daily activities, without clear evidence of "stepwise" progression. The age of onset of dementia was 66 years or less in five of the six patients. The duration of dementia ranged from 2 to 14 years. Five of the six cases had a history of either cerebral ischemia or acute stroke with residual focal neurologic deficits. Only two were known to have hypertension. At autopsy severe atherosclerosis of the cerebral arteries was present in three cases; two of these had a thrombotic occlusion of one internal carotid artery and one had partial obstruction of other cerebral arteries. In five of six brains, gross infarctions were present involving the thalamus, caudate, putamen, or large portions of the frontal, parietal, and temporal lobes of one or both hemispheres. Vascular amyloid was absent in all but one of these five brains. In four cases, the dementia was clinically indistinguishable from AD except for a history of focal neurologic deficits. The difficulty encountered in finding large numbers of cases of VaD without coexisting neuropathologic evidence of AD suggests that "pure" vascular dementia is very uncommon.
NEUROLOGY 1997;48: 668-672

Get full access to this article

View all available purchase options and get full access to this article.

REFERENCES

1.
Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992;42:473-480.
2.
Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-268.
3.
Rockwood K, Parhad I, Hachinski V, et al. Diagnosis of vascular dementia: Consortium of Canadian Centres for Clinical Cognitive Research consensus statement. Can J Neurol Sci 1994;21:358-364.
4.
Hachinski, VC. Multi-infarct dementia: a reappraisal. Alzheimer Dis Assoc Disord 1991;5:64-68.
5.
Erkinjuntti T, Haltia M, Palo J, Sulkava R, Paetau A. Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. J Neurol Neurosurg Psychiatry 1988;51:1037-1044.
6.
del Ser T, Bermejo F, Portera A, Arredondo JM, Bouras C, Constantinidis J. Vascular dementia: a clinicopathological study. J Neurosci 1990;96:1-17.
7.
Mirra SS, Heyman A, McKeel DW, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Part II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
8.
Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105.

Information & Authors

Information

Published In

Neurology®
Volume 48Number 3March 1997
Pages: 668-672
PubMed: 9065545

Publication History

Published online: March 1, 1997
Published in print: March 1997

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

From the Departments of Neurology (Drs. Hulette and Heyman) and Pathology (Dr. Hulette), Duke University, Durham, NC; the Department of Pathology (Drs. Nochlin and Sumi), the University of Washington, Seattle, WA; the Departments of Neurology (Dr. Morris) and Pathology (Dr. McKeel), Washington University, St. Louis, MO; and the Department of Pathology (Dr. Mirra), Emory University, Atlanta, GA.
Supported in part by NIH Grant AG06790.
Received July 25, 1996. Accepted in final form September 4, 1996.
Address correspondence and reprint requests to Dr. Christine Hulette, Duke University Medical Center, Box 2900, Durham, NC 27710.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. β-Amyloid promotes platelet activation and activated platelets act as bridge between risk factors and Alzheimer’s disease, Mechanisms of Ageing and Development, 207, (111725), (2022).https://doi.org/10.1016/j.mad.2022.111725
    Crossref
  2. Sudden confusion and cognitive decline due to acute infarction of the anterior thalamic nucleus (ANT) - a case report, MOJ Clinical & Medical Case Reports, 11, 5, (125-127), (2021).https://doi.org/10.15406/mojcr.2021.11.00397
    Crossref
  3. Dementia in the Forensic Setting: Diagnoses Obtained Using a Condensed Protocol at the Office of Chief Medical Examiner, New York City, Journal of Neuropathology & Experimental Neurology, 80, 8, (724-730), (2021).https://doi.org/10.1093/jnen/nlab059
    Crossref
  4. Amyloid PET in Dementia Syndromes: A Chinese Multicenter Study, Journal of Nuclear Medicine, 61, 12, (1814-1819), (2020).https://doi.org/10.2967/jnumed.119.240325
    Crossref
  5. Vascular Cognitive Impairment, CONTINUUM: Lifelong Learning in Neurology, 25, 1, (147-164), (2019).https://doi.org/10.1212/CON.0000000000000684
    Crossref
  6. Epidemiology of aging and associated cognitive disorders: Prevalence and incidence of Alzheimer's disease and other dementias, Geriatric Neurology, (139-148), (2019).https://doi.org/10.1016/B978-0-12-804766-8.00009-1
    Crossref
  7. Vascular dementia: A diagnosis running out of time, British Journal of Psychiatry, 180, 2, (152-156), (2018).https://doi.org/10.1192/bjp.180.2.152
    Crossref
  8. Review: Vascular dementia: clinicopathologic and genetic considerations, Neuropathology and Applied Neurobiology, 44, 3, (247-266), (2018).https://doi.org/10.1111/nan.12472
    Crossref
  9. APOE genotypes as a risk factor for age‐dependent accumulation of cerebrovascular disease in older adults , Alzheimer's & Dementia, 15, 2, (258-266), (2018).https://doi.org/10.1016/j.jalz.2018.08.007
    Crossref
  10. Extra-virgin Olive Oil, the Mediterranean Diet, and Neurodegenerative Diseases, Benefits of the Mediterranean Diet in the Elderly Patient, (81-95), (2018).https://doi.org/10.1007/978-3-319-78084-9_5
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share